Epirubicin/ifosfamide

Epirubicin/ifosfamide Reactions 1680, p128 - 2 Dec 2017 Marrow suppression and mucosal ulceration: case report A 29-year-old woman developed marrow suppression and mucosal ulceration during treatment with epirubicin and ifosfamide. The woman was scheduled to receive four cycles of adjuvant chemotherapy with ifosfamide and epirubicin [routes and dosages not stated] for pancreatic liposarcoma. The first cycle of the chemotherapy was initiated in July 2015. However, she developed severe chemotherapy associated adverse reactions (ADRs) such as mucosal ulceration and marrow suppression [duration of treatments to reactions onset and outcomes not stated]. The ADRs resulted in unwillingness to continue the medications. But, the woman decline to change her first-line chemotherapeutic treatment. She later had recurrence of liposarcoma and the chemotherapy was switched to apatinib. Author comment: ’’[T]he patient experienced severe chemotherapy related adverse reactions such as marrow suppression and mucosal ulceration, which resulted the hesitation of the medication use.’’ Han T, et al. Successful treatment of advanced pancreatic liposarcoma with apatinib: A case report and literature review. Cancer Biology and Therapy 18: 635-639, No. 9, 2017. Available from: URL: http:// doi.org/10.1080/15384047.2017.1345394 - China 803285409 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Epirubicin/ifosfamide

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page
Loading next page...
1 Page
 
/lp/springer_journal/epirubicin-ifosfamide-gIcT4K0Tk5
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39059-6
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p128 - 2 Dec 2017 Marrow suppression and mucosal ulceration: case report A 29-year-old woman developed marrow suppression and mucosal ulceration during treatment with epirubicin and ifosfamide. The woman was scheduled to receive four cycles of adjuvant chemotherapy with ifosfamide and epirubicin [routes and dosages not stated] for pancreatic liposarcoma. The first cycle of the chemotherapy was initiated in July 2015. However, she developed severe chemotherapy associated adverse reactions (ADRs) such as mucosal ulceration and marrow suppression [duration of treatments to reactions onset and outcomes not stated]. The ADRs resulted in unwillingness to continue the medications. But, the woman decline to change her first-line chemotherapeutic treatment. She later had recurrence of liposarcoma and the chemotherapy was switched to apatinib. Author comment: ’’[T]he patient experienced severe chemotherapy related adverse reactions such as marrow suppression and mucosal ulceration, which resulted the hesitation of the medication use.’’ Han T, et al. Successful treatment of advanced pancreatic liposarcoma with apatinib: A case report and literature review. Cancer Biology and Therapy 18: 635-639, No. 9, 2017. Available from: URL: http:// doi.org/10.1080/15384047.2017.1345394 - China 803285409 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680

Journal

Reactions WeeklySpringer Journals

Published: Dec 2, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from
Google Scholar,
PubMed
Create lists to
organize your research
Export lists, citations
Read DeepDyve articles
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off